Mechanisms and management of retinopathy of prematurity

N Engl J Med. 2012 Dec 27;367(26):2515-26. doi: 10.1056/NEJMra1208129.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants / therapeutic use
  • Erythropoietin / therapeutic use
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Very Low Birth Weight
  • Models, Animal
  • Oxygen / adverse effects
  • Retinal Vessels / growth & development*
  • Retinal Vessels / pathology
  • Retinopathy of Prematurity* / diagnosis
  • Retinopathy of Prematurity* / etiology
  • Retinopathy of Prematurity* / physiopathology
  • Retinopathy of Prematurity* / therapy
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antioxidants
  • Vascular Endothelial Growth Factor A
  • Erythropoietin
  • Oxygen